IRIS Accounts Production v18.1.0.975 09365429 Board of Directors Board of Directors 1.4.17 31.3.18 31.3.18 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure093654292017-03-31093654292018-03-31093654292017-04-012018-03-31093654292016-04-05093654292016-04-062017-03-31093654292017-03-3109365429ns15:EnglandWales2017-04-012018-03-3109365429ns14:PoundSterling2017-04-012018-03-3109365429ns10:Director12017-04-012018-03-3109365429ns10:Director22017-04-012018-03-3109365429ns10:PrivateLimitedCompanyLtd2017-04-012018-03-3109365429ns10:SmallEntities2017-04-012018-03-3109365429ns10:AuditExempt-NoAccountantsReport2017-04-012018-03-3109365429ns10:SmallCompaniesRegimeForDirectorsReport2017-04-012018-03-3109365429ns10:SmallCompaniesRegimeForAccounts2017-04-012018-03-3109365429ns10:FullAccounts2017-04-012018-03-3109365429ns10:Director32017-04-012018-03-3109365429ns10:Director42017-04-012018-03-3109365429ns10:RegisteredOffice2017-04-012018-03-3109365429ns5:CurrentFinancialInstruments2018-03-3109365429ns5:CurrentFinancialInstruments2017-03-3109365429ns5:Non-currentFinancialInstruments2018-03-3109365429ns5:Non-currentFinancialInstruments2017-03-3109365429ns5:ShareCapital2018-03-3109365429ns5:ShareCapital2017-03-3109365429ns5:SharePremium2018-03-3109365429ns5:SharePremium2017-03-3109365429ns5:RetainedEarningsAccumulatedLosses2018-03-3109365429ns5:RetainedEarningsAccumulatedLosses2017-03-3109365429ns5:PlantMachinery2017-04-012018-03-3109365429ns5:PlantMachinery2017-03-3109365429ns5:PlantMachinery2018-03-3109365429ns5:PlantMachinery2017-03-3109365429ns5:AdditionsToInvestments2018-03-3109365429ns5:CostValuation2018-03-3109365429ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-03-3109365429ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-03-31


REGISTERED NUMBER: 09365429 (England and Wales)















4Bio Ventures Management Ltd

Unaudited Financial Statements for the Year Ended 31 March 2018






4Bio Ventures Management Ltd (Registered number: 09365429)






Contents of the Financial Statements
for the Year Ended 31 March 2018




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


4Bio Ventures Management Ltd

Company Information
for the Year Ended 31 March 2018







DIRECTORS: Mr A Kozlov
Dr D Kuzmin
Mr N Katorzhnov
Mr K Mudryy



REGISTERED OFFICE: 78 Pall Mall
London
SW1Y 5ES



REGISTERED NUMBER: 09365429 (England and Wales)



ACCOUNTANTS: Chris Syrimis & Co
Chartered Certified Accountants
97 Judd Street
London
WC1H 9JG



BANKERS: Barclays Bank Plc
Holborn 2
Leicester
LE87 2BB

4Bio Ventures Management Ltd (Registered number: 09365429)

Statement of Financial Position
31 March 2018

31/3/18 31/3/17
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 8,628 2,627
Investments 5 878 -
9,506 2,627

CURRENT ASSETS
Debtors 6 187,540 6,400
Cash at bank 1,655,076 18,723
1,842,616 25,123
CREDITORS
Amounts falling due within one year 7 60,793 27,166
NET CURRENT ASSETS/(LIABILITIES) 1,781,823 (2,043 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,791,329

584

CREDITORS
Amounts falling due after more than one
year

8

68,818

-
NET ASSETS 1,722,511 584

CAPITAL AND RESERVES
Called up share capital 20 2
Share premium 2,295,797 -
Retained earnings (573,306 ) 582
SHAREHOLDERS' FUNDS 1,722,511 584

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2018 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the
Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as
at the end of each financial year and of its profit or loss for each financial year in accordance with the
requirements of Sections 394 and 395 and which otherwise comply with the requirements of the
Companies Act 2006 relating to financial statements, so far as applicable to the company.

4Bio Ventures Management Ltd (Registered number: 09365429)

Statement of Financial Position - continued
31 March 2018


The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors on 17 May 2018 and were signed on its
behalf by:




Mr A Kozlov - Director



Dr D Kuzmin - Director


4Bio Ventures Management Ltd (Registered number: 09365429)

Notes to the Financial Statements
for the Year Ended 31 March 2018

1. STATUTORY INFORMATION

4Bio Ventures Management Ltd is a private company, limited by shares , registered in England and
Wales. The company's registered number and registered office address can be found on the Company
Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding
discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement,
except to the extent that it relates to items recognised in other comprehensive income or directly in
equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been
enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at
the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods
different from those in which they are recognised in financial statements. Deferred tax is measured
using tax rates and laws that have been enacted or substantively enacted by the year end and that are
expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable
that they will be recovered against the reversal of deferred tax liabilities or other future taxable
profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at
the statement of financial position date. Transactions in foreign currencies are translated into sterling
at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account
in arriving at the operating result.

4Bio Ventures Management Ltd (Registered number: 09365429)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2018

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the
company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2017 - 2 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2017 3,502
Additions 8,783
At 31 March 2018 12,285
DEPRECIATION
At 1 April 2017 875
Charge for year 2,782
At 31 March 2018 3,657
NET BOOK VALUE
At 31 March 2018 8,628
At 31 March 2017 2,627

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
Additions 878
At 31 March 2018 878
NET BOOK VALUE
At 31 March 2018 878

4Bio Ventures Management Ltd (Registered number: 09365429)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2018

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/3/18 31/3/17
£    £   
Other debtors 22,172 -
Deferred tax asset 130,077 -
Prepayments 35,291 6,400
187,540 6,400

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/3/18 31/3/17
£    £   
Payments on account 5,776 -
Trade creditors 18,574 15,466
Taxation and social security 27,894 5,506
Other creditors 8,549 6,194
60,793 27,166

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
31/3/18 31/3/17
£    £   
Other creditors 68,818 -